Fig. 2From: Ergocalciferol treatment does Not improve erythropoietin utilization and hospitalization rate in hemodialysis patientsThe monthly requirement of paricalcitol dose (median [IQR]) over 1 year period in hemodialysis patients receiving ergocalciferol (n = 107, blue) or control (n = 79, red), p < 0.001Back to article page